114 related articles for article (PubMed ID: 1663548)
1. Transport of the new quinolone antibacterial agents of lomefloxacin and ofloxacin by rat erythrocytes, and its relation to the nicotinic acid transport system.
Simanjuntak MT; Sato H; Tamai I; Terasaki T; Tsuji A
J Pharmacobiodyn; 1991 Aug; 14(8):475-81. PubMed ID: 1663548
[TBL] [Abstract][Full Text] [Related]
2. Entry of the new quinolone antibacterial agents of ofloxacin and NY-198 into the central nervous system in rats.
Sato H; Okezaki E; Yamamoto S; Nagata O; Kato H; Tsuji A
J Pharmacobiodyn; 1988 Jun; 11(6):386-94. PubMed ID: 3171880
[TBL] [Abstract][Full Text] [Related]
3. Comparative penetration of lomefloxacin and other quinolones into human phagocytes.
Perea EJ; García I; Pascual A
Am J Med; 1992 Apr; 92(4A):48S-51S. PubMed ID: 1316071
[TBL] [Abstract][Full Text] [Related]
4. Serum protein binding of lomefloxacin, a new antimicrobial agent, and its related quinolones.
Okezaki E; Terasaki T; Nakamura M; Nagata O; Kato H; Tsuji A
J Pharm Sci; 1989 Jun; 78(6):504-7. PubMed ID: 2760827
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of new quinolones in the blood of elderly patients.
Morita M; Hasuda A; Nakagawa H; Abe Y; Suzuki K
J Int Med Res; 1993; 21(6):334-41. PubMed ID: 8143888
[TBL] [Abstract][Full Text] [Related]
6. Carrier-mediated uptake of nicotinic acid by rat intestinal brush-border membrane vesicles and relation to monocarboxylic acid transport.
Simanjuntak MT; Tamai I; Terasaki T; Tsuji A
J Pharmacobiodyn; 1990 May; 13(5):301-9. PubMed ID: 2273446
[TBL] [Abstract][Full Text] [Related]
7. In-vitro activity of lomefloxacin (SC-47111) and other quinolones.
Sun ZM; Maskell JP; Sehgal SC; Williams JD
Infection; 1989; 17(3):165-7. PubMed ID: 2737760
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
Robbins MJ; Baskerville AJ; Sanghrajka M; Mumtaz G; Felmingham D; Ridgway GL; Grüneberg RN
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):65S-76S. PubMed ID: 2791500
[TBL] [Abstract][Full Text] [Related]
9. Fluorometric and high-performance liquid chromatographic measurement of quinolone uptake by human neutrophils.
Pascual A; García I; Conejo MC; Perea EJ
Eur J Clin Microbiol Infect Dis; 1991 Nov; 10(11):969-71. PubMed ID: 1665416
[TBL] [Abstract][Full Text] [Related]
10. Differences in the hepatobiliary transport of two quinolone antibiotics, grepafloxacin and lomefloxacin, in the rat.
Sasabe H; Kato Y; Terasaki T; Tsuji A; Sugiyama Y
Biopharm Drug Dispos; 1999 Apr; 20(3):151-8. PubMed ID: 10211868
[TBL] [Abstract][Full Text] [Related]
11. A 19F NMR study of lomefloxacin in human erythrocytes and its interaction with hemoglobin.
Knaub SR; Priston MJ; Morton MD; Slechta JD; Vander Velde DG; Riley CM
J Pharm Biomed Anal; 1995 Sep; 13(10):1225-33. PubMed ID: 8562594
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of lomefloxacin and ofloxacin in complex therapy of infections in patients with burns].
Krutikov MG; Alekseev AA; Bobrovnikov AE; Grishina IA; Elagina LV; Izotova GN; Iakovlev VP
Antibiot Khimioter; 1998; 43(10):27-31. PubMed ID: 9825107
[TBL] [Abstract][Full Text] [Related]
13. Characterization of triiodothyronine transport and accumulation in rat erythrocytes.
Osty J; Jego L; Francon J; Blondeau JP
Endocrinology; 1988 Nov; 123(5):2303-11. PubMed ID: 3168926
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis.
Piersimoni C; Morbiducci V; Bornigia S; De Sio G; Scalise G
Am Rev Respir Dis; 1992 Dec; 146(6):1445-7. PubMed ID: 1333738
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of lomefloxacin (NY-198 or SC 47111).
Shah PM; Müller S; Kipp J; Stille W
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):97S-101S. PubMed ID: 2791506
[TBL] [Abstract][Full Text] [Related]
16. Lomefloxacin: microbiologic assessment and unique properties.
Mayer KH; Ellal JA
Am J Med; 1992 Apr; 92(4A):58S-62S. PubMed ID: 1316073
[TBL] [Abstract][Full Text] [Related]
17. Transport of quinolone antibacterial drugs by human P-glycoprotein expressed in a kidney epithelial cell line, LLC-PK1.
Ito T; Yano I; Tanaka K; Inui KI
J Pharmacol Exp Ther; 1997 Aug; 282(2):955-60. PubMed ID: 9262363
[TBL] [Abstract][Full Text] [Related]
18. Effect of ranitidine on renal clearance of lomefloxacin.
Sudoh T; Fujimura A; Harada K; Sunaga K; Ohmori M; Sakamoto K
Eur J Clin Pharmacol; 1996; 51(1):95-8. PubMed ID: 8880059
[TBL] [Abstract][Full Text] [Related]
19. [In vitro evaluation of lomefloxacin].
Dette GA; Knothe H
Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
[TBL] [Abstract][Full Text] [Related]
20. Transport of quinolone antibacterial drugs in a kidney epithelial cell line, LLC-PK1.
Matsuo Y; Yano I; Ito T; Hashimoto Y; Inui K
J Pharmacol Exp Ther; 1998 Nov; 287(2):672-8. PubMed ID: 9808695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
